174 related articles for article (PubMed ID: 8105963)
1. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
Rodrigues A; Cabrita A; Maia P; Guimarães S
Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
[TBL] [Abstract][Full Text] [Related]
4. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.
Coronel F; Tornero F; Macia M; Sánchez A; De Oleo P; Naranjo P; Barrientos A
Adv Perit Dial; 1991; 7():35-8. PubMed ID: 1680453
[TBL] [Abstract][Full Text] [Related]
6. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
Nakamoto H; Imai H; Kawanishi H; Nakamoto M; Minakuchi J; Kumon S; Watanabe S; Shiohira Y; Ishii T; Kawahara T; Suzuki H
Adv Perit Dial; 2001; 17():238-43. PubMed ID: 11510284
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
[TBL] [Abstract][Full Text] [Related]
8. [The effect of frequent peritonitis on parameters of efficacy of peritoneal dialysis].
Kostić S; Velicković R; Ljubenović S; Raicević R; Stefanović V; Veljković S; Cukuranović R; Radenković S; Djordjević V; Antić S
Srp Arh Celok Lek; 1996; 124 Suppl 1():153-5. PubMed ID: 9102886
[TBL] [Abstract][Full Text] [Related]
9. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
11. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis E
Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
[TBL] [Abstract][Full Text] [Related]
12. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
Drachman R; Niaudet P; Gagnadoux MF; Broyer M
Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
14. Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance.
Reyes MJ; Bajo MA; Hevía C; Del Peso G; Ros S; de Miguel AG; Cirugeda A; Castro MJ; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2007 Jan; 22(1):218-23. PubMed ID: 17005522
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
Vega N; Fernandez A; Hortal L; Macias M; Rodriguez JC; Plaza C; Perdomo M; Vega R; Palop L
Adv Perit Dial; 1992; 8():467-70. PubMed ID: 1361850
[TBL] [Abstract][Full Text] [Related]
16. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
17. Nitrate in stable CAPD patients and during peritonitis.
Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
[TBL] [Abstract][Full Text] [Related]
18. Dialysate CA125 in stable CAPD patients: no relation with transport parameters.
Pannekeet MM; Koomen GC; Struijk DG; Krediet RT
Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125
[TBL] [Abstract][Full Text] [Related]
19. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
20. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis?
Ota K; Mineshima M; Watanabe N; Naganuma S
Nephrol Dial Transplant; 1987; 2(1):30-3. PubMed ID: 3110694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
